Bausch Health Companies Inc (NYSE:BHC) has a beta value of 0.41 and has seen 0.94 million shares traded in the recent trading session. The company, currently valued at $1.75B, closed the recent trade at $4.72 per share which meant it lost -$0.38 on the day or -7.35% during that session. The BHC stock price is -108.69% off its 52-week high price of $9.85 and 16.1% above the 52-week low of $3.96. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.16 million shares traded. The 3-month trading volume is 2.99 million shares.
The consensus among analysts is that Bausch Health Companies Inc (BHC) is Hold stock at the moment, with a recommendation rating of 3.17. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 4 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.86.
Bausch Health Companies Inc (NYSE:BHC) trade information
Sporting -7.35% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BHC stock price touched $4.72 or saw a rise of 10.27%. Year-to-date, Bausch Health Companies Inc shares have moved -41.38%, while the 5-day performance has seen it change 9.37%. Over the past 30 days, the shares of Bausch Health Companies Inc (NYSE:BHC) have changed -33.73%. Short interest in the company has seen 7.85 million shares shorted with days to cover at 5.22.
Wall Street analysts have a consensus price target for the stock at $10, which means that the shares’ value could jump 52.8% from the levels at last check today.. The projected low price target is $10.0 while the price target rests at a high of $10.0. In that case, then, we find that the latest price level in today’s session is -111.86% off the targeted high while a plunge would see the stock gain -111.86% from the levels at last check today..
Bausch Health Companies Inc (BHC) estimates and forecasts
The company’s shares have lost -44.15% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 3.65%.
6 analysts offering their estimates for the company have set an average revenue estimate of 2.29B for the current quarter. 6 have an estimated revenue figure of 2.48B for the next ending quarter. Year-ago sales stood 2.15B and 2.4B respectively for this quarter and the next, and analysts expect sales will grow by 6.31% for the current quarter and 3.65% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 52.33% over the past 5 years. Earnings growth for 2025 is a modest 7.07% while over the next 5 years, the company’s earnings are expected to increase by 11.97%.
BHC Dividends
Bausch Health Companies Inc is expected to release its next earnings report on 2025-Feb-19 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Bausch Health Companies Inc (NYSE:BHC)’s Major holders
Insiders own 10.83% of the company shares, while shares held by institutions stand at 70.46% with a share float percentage of 79.02%. Investors are also buoyed by the number of investors in a company, with Bausch Health Companies Inc having a total of 307.0 institutions that hold shares in the company. The top two institutional holders are ICAHN CARL C with over 34.72 million shares worth more than $242.01 million. As of 2024-06-30, ICAHN CARL C held 9.4377% of shares outstanding.
The other major institutional holder is PAULSON & CO. INC., with the holding of over 26.44 million shares as of 2024-06-30. The firm’s total holdings are worth over $184.28 million and represent 7.1865% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Franklin Custodian Funds-FRANKLIN INCOME FUND and VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund . As of Dec 31, 2024 , the former fund manager holds about 1.36% shares in the company for having 5.0 shares of worth $23.52 million while later fund manager owns 4.21 shares of worth $19.83 million as of Jan 31, 2025 , which makes it owner of about 1.15% of company’s outstanding stock.
